Keywords: arqule, completes, 30m, financing, biotechnology, firm, says

ArQule completes $30M financing

Article | 07 February 2005

US biotechnology firm ArQule says that it has closed its previously-announced registered direct offering. The company sold approximately 5.78 million shares ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Novartis

Pfizer

Go to company listing